Journal
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
Volume 73, Issue 1, Pages 60-70Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09637486.2021.1910630
Keywords
Isoflavones; hypertension; hyperlipidaemia; NAFLD; public health data
Categories
Funding
- National Natural Science Fund of China [81872616, 81573133]
Ask authors/readers for more resources
Total isoflavones, daidzein, and genistein intake were found to be inversely associated with NAFLD, hyperlipidaemia, and hypertension. Glycitein was inversely associated with hyperlipidaemia and hypertension.
This study investigated associations between total isoflavones and their categories (daidzein, genistein, glycitein) intake and the risks for metabolic disorders. We used the data of 6786 Chinese adults from the Nutrition Health Atlas Project. We performed multiple logistic regression and restricted cubic spline models assessing the risks for metabolic disorders (non-alcoholic fatty liver disease (NAFLD), hyperlipidaemia, hypertension, diabetes and overweight/obesity) in each category of isoflavones. Higher total isoflavones, daidzein and genistein intake were inversely associated with NAFLD (p < .05). Higher total isoflavones, daidzein, genistein and glycitein intake were also inversely associated with hyperlipidaemia (p < .01) and hypertension (p < .01). Dose-response analyses revealed that total isoflavones, daidzein, genistein and glycitein intakes were associated with the risks of metabolic disorders in a nonlinear trend. In conclusion, total isoflavones, daidzein and genistein intake were inversely associated with NAFLD, hyperlipidaemia and hypertension. Glycitein was inversely associated with hyperlipidaemia and hypertension.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available